PRIMARY INVASIVE SQUAMOUS CARCINOMA OF THE VAGINA
- 1 January 1979
- journal article
- research article
- Vol. 53 (2) , 218-225
Abstract
Cases (43) of primary vaginal squamous cell cancer were treated between 1956-71. These cases comprised 1.2% of patients admitted with female genital tract cancer. Evidence is presented to support a modification of the currently accepted FIGO [International Federation of Gynecology and Obstetrics] staging system for vaginal carcinoma (Stage II disease). Radiation therapy using both external beam and brachyradium equivalents or interstitial implantation of suitable isotopes was an effective method for the treatment of patients having early and locally advanced invasive vaginal cancer. The 5 yr absolute survival rate for the entire series was 37.2%. Absolute survival rate by modified FIGO clinical staging was 66% for Stages I and IIA, 31% for Stage IIB, 25% for Stage III and 0% for Stage IV.This publication has 6 references indexed in Scilit:
- The importance of stromal inflammation in squamous cell carcinoma of the tongueJournal of Oral Pathology & Medicine, 2011
- Hydroxyurea as a radiation sensitizer in women with carcinoma of the uterine cervixAmerican Journal of Obstetrics and Gynecology, 1977
- Carcinoma of vagina 10 or more years following pelvic irradiation therapyAmerican Journal of Obstetrics and Gynecology, 1977
- Fast neutron radiotherapy for locally advanced pelvic cancerCancer, 1976
- PREMALIGNANT LESIONS OF THE VAGINAClinical Obstetrics and Gynecology, 1962
- In situ epidermoid carcinoma of the cervix and vagina following radiotherapy for cervical cancerCancer, 1961